Market Overview:
The global thromboelastography analyzer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, technological advancements in thromboelastography analyzers, and rising demand for point-of-care testing. Based on type, the global thromboelastography analyzer market is segmented into single channel and double channel, four channels, and others. The single channel segment is expected to account for the largest share of the global market in 2018 owing to its low cost and easy availability. However, the double channel segment is projected to grow at a higher CAGR during the forecast period as it offers better accuracy than single channel devices. Based on application, hospitals are expected to account for the largest share of the global market in 2018 followed by maternal and child health services (MCHS). Hospitals are increasingly adopting thromboelastography analyzers for early diagnosis and treatment of patients with clotting disorders while MCHS are using these devices for prenatal care screening purposes.
Product Definition:
A thromboelastography analyzer is a device that is used to measure the clotting time and strength of a blood clot. This information can be used to help determine the risk of a patient developing a blood clot. The importance of this type of analyzer is that it can help doctors identify patients who are at risk for developing blood clots and take steps to prevent them from happening.
Single and Double Channel:
Single channel thromboelastography (SCT) is a method used to measure the speed of blood flow through a single microcirculation. It provides valuable information about the functional state of small arteries and veins, which are important for understanding cardiovascular diseases. The test also helps in monitoring therapy response in patients with chronic heart failure.
The global Single and Double Channel, it's usage.
Four Channels:
The four channels test is used to measure the degree of coagulation in patients with acute coronary syndrome (ACS) or myocardial infarction. It also helps in monitoring the response of anticoagulants and heparin to a thrombolytic drug. The test uses an automated analyzer which measures different components such as fibrinogen, D-dimer, platelet count and plasma viscosity.
Application Insights:
The others segment includes research applications and other applications. Other applications include commercial application, hospital laboratory, maternal and child health service, and others. The hospital segment dominated the global thromboelastography analyzer market in 2017 due to a large number of tests performed in hospitals on a daily basis. This is mainly because these services are provided free of charge at hospitals for most common diseases that affect mostly the general population such as heart attack or stroke symptoms. However, this service is not available at all times as availability varies from place to place depending on demand from patients who need immediate medical attention regarding their conditions.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and increasing healthcare expenditure in this region. Moreover, favorable reimbursement policies are also expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels and improving healthcare infrastructure coupled with growing awareness about thromboelastography analyzers among patients and physicians.
Moreover, Latin America has also witnessed significant rise in demand for thromboelastography analyzers due to factors such as economic development & improvement in living standards along with a rise in cardiovascular diseases (CVDs).
Growth Factors:
- Increasing incidence of thrombotic disorders: The global incidence of thrombotic disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and dietary habits, growing aging population, and increasing prevalence of chronic diseases. This is expected to drive the demand for thromboelastography analyzers in the coming years.
- Technological advancements: The development of novel technologies in thromboelastography analyzers has revolutionized the diagnosis and treatment of patients with coagulation disorders. This is expected to boost the growth prospects of this market in the coming years.
- Growing awareness about coagulation disorders: There is a growing awareness among people about coagulation disorders such as hemophilia and von Willebrand disease (vWD). This has led to an increase in demand for diagnostic tests such as thromboelastography analyzers for early diagnosis and treatment planning purposes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thromboelastography Analyzer Market Research Report
By Type
Single and Double Channel, Four Channels, Others
By Application
Hospital, Maternal and Child Health Service, Laboratory, Others
By Companies
Haemonetics, Lepu Technology, Biomart, Medcaptain, Ud-bio, Chongqing Nanfang, WITEYE, Render, Guizhou Jinjiu Biotech, Chongqing Dingrun, Zhejiang Shengyu, Bio-zircon, WerfenLife, Framar Hemologix srl, Sienco
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Thromboelastography Analyzer Market Report Segments:
The global Thromboelastography Analyzer market is segmented on the basis of:
Types
Single and Double Channel, Four Channels, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Maternal and Child Health Service, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haemonetics
- Lepu Technology
- Biomart
- Medcaptain
- Ud-bio
- Chongqing Nanfang
- WITEYE
- Render
- Guizhou Jinjiu Biotech
- Chongqing Dingrun
- Zhejiang Shengyu
- Bio-zircon
- WerfenLife
- Framar Hemologix srl
- Sienco
Highlights of The Thromboelastography Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single and Double Channel
- Four Channels
- Others
- By Application:
- Hospital
- Maternal and Child Health Service
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thromboelastography Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A thromboelastography analyzer is a medical device that measures the amount of thrombus in a blood sample. This information can help doctors determine if there is an increased risk for heart attack or stroke.
Some of the key players operating in the thromboelastography analyzer market are Haemonetics, Lepu Technology, Biomart, Medcaptain, Ud-bio, Chongqing Nanfang, WITEYE, Render, Guizhou Jinjiu Biotech, Chongqing Dingrun, Zhejiang Shengyu, Bio-zircon, WerfenLife, Framar Hemologix srl, Sienco.
The thromboelastography analyzer market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thromboelastography Analyzer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thromboelastography Analyzer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thromboelastography Analyzer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thromboelastography Analyzer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thromboelastography Analyzer Market Size & Forecast, 2018-2028
4.5.1 Thromboelastography Analyzer Market Size and Y-o-Y Growth
4.5.2 Thromboelastography Analyzer Market Absolute $ Opportunity
Chapter 5 Global Thromboelastography Analyzer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thromboelastography Analyzer Market Size Forecast by Type
5.2.1 Single and Double Channel
5.2.2 Four Channels
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thromboelastography Analyzer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thromboelastography Analyzer Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Maternal and Child Health Service
6.2.3 Laboratory
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thromboelastography Analyzer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thromboelastography Analyzer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thromboelastography Analyzer Analysis and Forecast
9.1 Introduction
9.2 North America Thromboelastography Analyzer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thromboelastography Analyzer Market Size Forecast by Type
9.6.1 Single and Double Channel
9.6.2 Four Channels
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thromboelastography Analyzer Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Maternal and Child Health Service
9.10.3 Laboratory
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thromboelastography Analyzer Analysis and Forecast
10.1 Introduction
10.2 Europe Thromboelastography Analyzer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thromboelastography Analyzer Market Size Forecast by Type
10.6.1 Single and Double Channel
10.6.2 Four Channels
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thromboelastography Analyzer Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Maternal and Child Health Service
10.10.3 Laboratory
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thromboelastography Analyzer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thromboelastography Analyzer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thromboelastography Analyzer Market Size Forecast by Type
11.6.1 Single and Double Channel
11.6.2 Four Channels
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thromboelastography Analyzer Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Maternal and Child Health Service
11.10.3 Laboratory
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thromboelastography Analyzer Analysis and Forecast
12.1 Introduction
12.2 Latin America Thromboelastography Analyzer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thromboelastography Analyzer Market Size Forecast by Type
12.6.1 Single and Double Channel
12.6.2 Four Channels
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thromboelastography Analyzer Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Maternal and Child Health Service
12.10.3 Laboratory
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thromboelastography Analyzer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thromboelastography Analyzer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thromboelastography Analyzer Market Size Forecast by Type
13.6.1 Single and Double Channel
13.6.2 Four Channels
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thromboelastography Analyzer Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Maternal and Child Health Service
13.10.3 Laboratory
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thromboelastography Analyzer Market: Competitive Dashboard
14.2 Global Thromboelastography Analyzer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics
14.3.2 Lepu Technology
14.3.3 Biomart
14.3.4 Medcaptain
14.3.5 Ud-bio
14.3.6 Chongqing Nanfang
14.3.7 WITEYE
14.3.8 Render
14.3.9 Guizhou Jinjiu Biotech
14.3.10 Chongqing Dingrun
14.3.11 Zhejiang Shengyu
14.3.12 Bio-zircon
14.3.13 WerfenLife
14.3.14 Framar Hemologix srl
14.3.15 Sienco
